EVO Stock Summary and Trading Ideas (Evotec Se - American Depositary Shares Each Representing 1/2 Of One Ordinary Share | NASDAQ:EVO)

Evotec SE is a life science company focused on developing pharmaceutical products through standalone services, integrated R&D programs, and strategic partnerships with pharmaceutical and biotechnology companies, academic institutions, and other partners. It operates across drug discovery, preclinical development, and manufacturing, with expertise in areas including oncology, central nervous system, cardiovascular-renal, immune and inflammatory, infectious, and other diseases. The Company generates revenue through fee-for-service and FTE-based services, milestones, and royalties, and equity ownership in biotechnology and academic projects. It operates through the Shared R&D and Discovery & Preclinical Development (D&PD) segments, with the majority of revenue generated from the USA.

Evotec Se - American Depositary Shares Each Representing 1/2 Of One Ordinary Share trades on the NASDAQ stock market under the symbol EVO.

As of July 2, 2026, EVO stock price climbed to $2.93 with 2,898 million shares trading.

EVO has a beta of 2.67, meaning it tends to be more sensitive to market movements. EVO has a correlation of 0.29 to the broad based SPY ETF.

EVO has a market cap of $1.04 billion. This is considered a Small Cap stock.

Last quarter Evotec Se - American Depositary Shares Each Representing 1/2 Of One Ordinary Share reported $183 million in Revenue and -$.40 earnings per share. This fell short of revenue expectation by $-14 million and missed earnings estimates by -$.48.

In the last 3 years, EVO traded as high as $13.49 and as low as $2.31.

EVO has underperformed the market in the last year with a return of -30.6%, while SPY returned +22.1%. This shows that you would have done better investing in the overall market (through SPY) over the last year than in EVO shares. However, EVO has outperformed the market in the last 3 month and 2 week periods, returning +15.4% and +12.3%, while SPY returned +14.3% and +1.3%, respectively. This indicates EVO has been having a stronger performance recently.

EVO support price is $2.77 and resistance is $2.93 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that EVO shares will trade within this expected range on the day.